Legend Biotech US logo

R&D, Leadership Development Associate

Legend Biotech US

Philadelphia, PAHybridPosted 1 day ago$127,313 - $167,099/year
Full TimeEntry LevelResearch & ScientistBiotechnology
Original posting ↗

Summary

The Early Career Leadership Program at Legend Biotech is a strategic, enterprise-focused development experience designed to accelerate the growth of high-potential professionals early in their careers. Rooted in our commitment to cultivating enterprise-minded, value-driven leaders, this program provides structured rotational exposure, executive mentorship, and real-time business impact across scientific, operational, and corporate functions. This immersive experience is built to cultivate scientific leaders capable of translating discoveries into development, advancing complex pipeline programs, and influencing cross-functional strategy.

Job description

Role Overview

The Early Career Leadership Program at Legend Biotech is a strategic, enterprise-focused development experience designed to accelerate the growth of high-potential professionals early in their careers. Rooted in our commitment to cultivating enterprise-minded, value-driven leaders, this program provides structured rotational exposure, executive mentorship, and real-time business impact across scientific, operational, and corporate functions. This immersive experience is built to cultivate scientific leaders capable of translating discoveries into development, advancing complex pipeline programs, and influencing cross-functional strategy.

Key Responsibilities

  • Participate in solid tumor team's routine drug development candidate selection to support pipeline development.
  • Participate in the development of new in-house enabling technology for solid tumor, including new armor design and testing, in vitro model development, assay development, single cell characterization.
  • Propose new initiatives for solid tumor in vivo CAR-T and work with cross-functional team for execution.

Requirements

  • Recent PhD graduate (within the last 5 years) in Biological Sciences, Immunology, Biochemistry, Cell Biology, or related life sciences discipline.
  • 2-3 years of research experience (academic or industry); life sciences, immunology, oncology, or translational research experience preferred.
  • Experience in cell therapy, cancer immunotherapy, or solid tumor research is preferred.
  • Research experience in solid tumor immunology, including mechanisms of immune suppression, tumor-infiltrating myeloid populations, dendritic cells (DCs), macrophages, regulatory immune networks, and strategies to modulate the tumor microenvironment is preferred.
  • Experience developing antibody-based, cellular, or multi-modal immunotherapies directed against tumor cells and/or immunosuppressive cell populations within the tumor microenvironment is highly desirable.
  • Experience with in vitro and in vivo immunology, tumor biology, immune profiling, functional characterization, and translational research approaches is preferred.
  • Demonstrated record of scientific rigor, innovation, intellectual curiosity, analytical thinking, and scientific productivity.
  • Ability to work independently and collaboratively in a highly cross-functional and fast-paced research environment.
  • Proficiency with standard scientific data analysis and visualization software, including FlowJo, GraphPad Prism, Microsoft Office, and related research tools.
  • Experience with data analysis, interpretation, and presentation of complex biological datasets.
  • Familiarity with computational, bioinformatics, or data science tools commonly used in biological research is a plus.
  • Familiarity with AI tools such as Microsoft Copilot, ChatGPT, or Gemini is required.

Requirements

  • Recent PhD graduate (within the last 5 years) in Biological Sciences, Immunology, Biochemistry, Cell Biology, or related life sciences discipline
  • 2-3 years of research experience (academic or industry)
  • Experience in cell therapy, cancer immunotherapy, or solid tumor research preferred
  • Research experience in solid tumor immunology preferred
  • Experience developing antibody-based, cellular, or multi-modal immunotherapies highly desirable
  • Experience with in vitro and in vivo immunology, tumor biology, immune profiling, functional characterization, and translational research approaches preferred
  • Demonstrated record of scientific rigor, innovation, intellectual curiosity, analytical thinking, and scientific productivity
  • Ability to work independently and collaboratively in a highly cross-functional and fast-paced research environment
  • Proficiency with FlowJo, GraphPad Prism, Microsoft Office, and related research tools
  • Experience with data analysis, interpretation, and presentation of complex biological datasets
  • Familiarity with computational, bioinformatics, or data science tools is a plus
  • Familiarity with AI tools such as Microsoft Copilot, ChatGPT, or Gemini is required
  • Must be authorized to work in the United States

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Paid Parental Leave
  • Paid Time Off
  • Flexible Spending Account
  • Health Savings Account
  • Life & AD&D Insurance
  • Short & Long-Term Disability
  • Legal Assistance
  • Pet Insurance
  • Critical Illness Insurance
  • Accident Insurance
  • Hospital Indemnity Insurance
  • Commuter Benefits
  • Performance Bonus
  • Equity

Company overview

Legend Biotech is a global, commercial-stage biotechnology company specializing in the development and manufacturing of advanced cell therapies. Headquartered in Somerset, New Jersey, the company was founded in 2014 and has grown to become a leader in the cell therapy space with over 2,600 employees worldwide. Legend Biotech focuses on innovative cellular immunotherapy platforms, including autologous and allogeneic chimeric antigen receptor T-cell (CAR-T) therapies, natural killer (NK) cell-based immunotherapies, and non-gene-editing universal CAR-T technologies. The company's flagship product, CARVYKTI® (ciltacabtagene autoleucel), developed in collaboration with Johnson & Johnson, is a BCMA-directed CAR-T therapy approved for the treatment of relapsed or refractory multiple myeloma. With a robust pipeline of 11 investigational therapies spanning multiple disease areas, Legend Biotech operates research and development facilities across the United States, Europe, and China, maintaining a strong commitment to transforming patient care through cutting-edge cellular therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.